VGG-20053-38774
4 vaccinations
3 coded responses
42 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 191 / PA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-04
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-11
- 2021-07-12
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Fatigue or tirednessFree text: Adenopathy axillaMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-10-08
Health check-in — day 7, dose 3Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
- 2021-10-15
- 2021-10-22
- 2021-10-31
-
2021-11-06
Survey response — day 35, dose 3MedDRA: Back pain, Injection site discomfort, Injection site induration, Injection site pain, Pain in extremity — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Ongoing arm pain and discomfort at injection site, has indurated area under it. Now with sharp pains both in lower arm and upper back associated with this discomfort. This has continued to get worse over the past several weeks and never got betterMedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-11
Call successfulDoes not wish to fill out VAERS report
- 2022-01-01
- 2022-04-02
-
2022-09-18
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-22
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2022-09-23
- 2022-09-27
- 2022-10-02
-
2022-10-09
Survey response — day 21, dose 4MedDRA: Ectopic pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Ectopic pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-09
Report sent to call center — day 21, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-10-10
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-09-18 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-06 | Successful 2021-11-11 |
Does not wish to fill out VAERS report |
| 2022-10-09 | Successful 2022-10-10 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Adenopathy axilla
Release 10 — day 35, dose 3
Symptoms: Ongoing arm pain and discomfort at injection site, has indurated area under it. Now with sharp pains both in lower arm and upper back associated with this discomfort. This has continued to get worse over the past several weeks and never got better
Release 12 — day 21, dose 4
Symptoms: Ectopic pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | · | · | ✓ |
| SD | Ectopic pregnancy | · | · | ✓ |
| SD | Injection site discomfort | · | · | ✓ |
| SD | Injection site induration | · | · | ✓ |
| SD | Injection site pain | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release